Navigation Links
EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Date:5/30/2008

DURHAM, N.C., May 30 /PRNewswire/ -- Dr. George C. Clark of Xenobiotic Detection Systems (XDS) and Dr. Michael Denison at the University of California Davis, with support from the Superfund Basic Research Program, have developed a rapid and inexpensive recombinant cell bioassay system for the detection and relative quantification of dioxin-like chemicals. Dioxin-like chemicals are some of the most toxic chemicals known.

The CALUX(R) by XDS (Chemical Activated LUciferase Gene Expression) system has recently been published and is posted under "New Methods" on the SW-846 website. In March 2008, the EPA's Office of Solid Waste (OSW) Organic Methods Workgroup formally reviewed and approved Method 4435 for inclusion into Test Methods for Evaluating Solid Waste, Physical/Chemical Methods, also known as SW-846. The XDS-CALUX system consists of a unique sample processing method linked with a sensitive gene expression cell bioassay detection system providing unique sensitivity and selectivity for quantifying dioxin-like chemicals.

The XDS-CALUX(R) bioassay costs are 40%-70% lower than the traditional High Resolution Gas Chromatography/Mass Spectrometry (HR GC/MS) that was the old singular analysis standard. Xenobiotic Detection Systems Method 4435 provides an excellent screening tool to rapidly detect and quantify these ubiquitous and toxic environmental contaminants.

"This approval exemplifies the assay's versatility and is another major step for XDS," says President of XDS, Dr. George Clark. "Having been certified in the European Union since 2002 to primarily monitor feed and food it is wonderful to receive accreditation here in the U.S. Our screening analysis method is faster, far more affordable, and in many cases even more sensitive than the traditional HR GC/MS. The EPA's approval will allow us to better serve our clients and safeguard the environment from these toxic contaminants."

Research Institutes Worldwide using XDS-CALUX(R) Tech
'/>"/>

SOURCE Xenobiotic Detection Systems
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...CISCO, Calif., Nov. 9 An...on November 5, 2009, it received a letter from The...he Nasdaq Hearing Panel has granted Anesiva,s requ...ket subject to the condition that Anesiva shall ha...roposed merger (the "Merger") contemplated by the ...
(Date:11/7/2009)...la., Nov. 7 Patients reported C1-e...tive therapy in treating acute swelling attacks at...etic disorder, according to data presented today a...p; Immunology (ACAAI) Annual Meeting. The results ...cted in parallel with the ongoing, prospective, op...
(Date:11/6/2009)... WASHINGTON, Pa., Nov. 6 In consul...(FDA), McNeil Consumer Healthcare, Division of McN... a limited number of product lots of TYLENOL®... distinctive red EZ-OPEN CAP. McNeil is initiating...smell or taste associated with these lots that led...
Breaking Medicine Technology:Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 1Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 2Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 3Abnormal Protein May Signal Pancreatic Cancer 54730 1Abnormal Protein May Signal Pancreatic Cancer 54730 2Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 1Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 2Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 3
...th Lovenox(R) (enoxaparin sodium injection) were a...l within 90 days-, BRIDGEWATER, N.J., Dec 10 San... that demonstrated total hospital,direct medical c...$550 per,patient when they were treated with the u...actionated heparin (UFH) with 97.3% of LMWH patien...
... 10 Alfacell Corporation,(Nasdaq: ACEL ) today r...r,of fiscal 2008., The company recorded a net los...c and diluted common share, for the fiscal quarter...ion, or $0.05 per basic and diluted,common share, ...administrative expenses increased by approximately...
Other Medicine Technology:Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5Alfacell Reports Financial Results for First Quarter of Fiscal 2008 2Alfacell Reports Financial Results for First Quarter of Fiscal 2008 3Alfacell Reports Financial Results for First Quarter of Fiscal 2008 4Alfacell Reports Financial Results for First Quarter of Fiscal 2008 5
(Date:11/9/2009)...N, Nov. 9 Today,s drama...gs us one step closer to meaningful health care re...th Care for America Act makes health care more acc...y enhancing coverage, promoting preventive care an...lso serves as a sober reminder of the tremendous a...
(Date:11/9/2009)... New Health Care Reform Bill, The Afford...he House Of Representatives Saturday Night, and Is...bama by the End of the Year with Absolute Confiden...alist Certification Class Specifically for the Com...% of Americans , Hanover ...
(Date:11/9/2009)... Only 5 percent of seniors have changed ...avings, better service and improved coverage among...llment season nears , , B...ly 5 percent of seniors have changed their Medicar...y (16 percent) report they are likely to or are co...
(Date:11/9/2009)...inds that women treated for breast cancer are at h... breasts. Published in the December 15, 2009 issue...can Cancer Society, the study,s results indicate t...benefit from additional therapies following surger...e that women with dense breast tissue are at incre...
(Date:11/8/2009)...HIA, Nov. 8 The America...evention and wellness provisions in the health ref...th passage of this bill, the House takes important...tant insurance reforms and moving our health syste...e that focuses on keeping people healthy," said Ge...
Breaking Medicine News(10 mins):Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 2Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 3Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 4Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 5Health News:Breast density associated with increased risk of cancer recurrence 2Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2
...The U-C-L-A Medical Center, in Los Angeles is witn...on after a heart transplant. His twin, also in nee...// Nick and Nate Draper, the twin brothers wer...enter. According to the Doctors, Nick Draper...
... study led by Ronald Hines, professor of pediatric...ult and children have very different drug metaboli...s (enzymes) in their body for the processing of th...e young. This plays a vital role because certa...
...ior doctor has by the means of BMJ raised a seriou...alization purposes. // This has come after n... approved and thereafter recalled after three mont... Drug Administration in 2004 on the basis of short...
...ses like diabetes, cancer and heart attack that ar...s could cause much strain to the Indian economy, /...ost by 2015, according to estimates by World Healt...s Robert Beaglehole, director of NCD, WHO. H...
...us concerns have been raised regarding the safety ...ports of increased risk of autism // in children ...st mumps, measles and rubella. Currently, ch...nt vaccine preventable diseases. The government ha...
...ed River Valley Water Supply Project's key agenda ...stern North Dakota, especially heavily populated a...ronmental groups are up in arms against this propo...eels that a task of such a magnitude , interbasin ...
Other Medicine News:
Moody Curved Fixation Forceps
Lindstrom Curved Pierce Forcep
Green Fixation Forceps
Kuhnt Fixation Forceps
Medicine Products: